Allena Pharmaceuticals

$4.19
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.01 (-0.24%) Today
-$0.04 (-0.95%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell ALNA and other stocks, options, ETFs, and crypto commission-free!

About ALNA

Allena Pharmaceuticals, Inc. Common Stock, also called Allena Pharmaceuticals, is a late-stage clinical biopharmaceutical company, which engages in the development, discovery, and commercialization of oral enzyme therapeutics to treat patients with kidney disorders. Read More Its product pipeline includes Reloxaliase, an oral enzyme therapeutic for the treatment of enteric hyperoxaluria in adults; and ALLN-346, which is used for patients with hyperuricemia and moderate to severe chronic kidney disease. The company was founded by Robert Gallotto and Alexey L. Margolin on June 24, 2011 and is headquartered in Newton, MA.

Employees
Headquarters
Newton, Massachusetts
Founded
2011
Market Cap
99.26M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
34.07K
High Today
$4.29
Low Today
$4.07
Open Price
$4.27
Volume
10.26K
52 Week High
$11.82
52 Week Low
$3.62

Collections

ALNA Earnings

-$0.58
-$0.51
-$0.45
-$0.38
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Estimated
Actual
Expected Nov 7, Pre-Market
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.